Showing results (191-200 of 281) with videos related to
Sort By:
Pageof 29
Journal of the American Chemical Society|May 22, 2014
A genetically encoded aza-Michael acceptor for covalent cross-linking of protein-receptor complexesJennifer L Furman, Mingchao Kang, Seihyun Choi, et al.Pediatric Blood & Cancer|June 16, 2007
Reducing irinotecan-associated diarrhea in childrenLars M Wagner, Kristine R Crews, Clinton F Stewart, et al.Pediatric Blood & Cancer|February 3, 2015
The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastomaSara M Federico, Samuel L Brady, Alberto Pappo, et al.Annals of Surgical Oncology|July 3, 2021
Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk NeuroblastomaSara A Mansfield, M Beth McCarville, John T Lucas, et al.Blood|December 1, 1986
Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemiaC H Pui, S C Raimondi, F G Behm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group studyVictor M Aquino, Steve D Weitman, Naomi J Winick, et al.Cancer|November 17, 2005
The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital ExperienceLisa M McGregor, Bhaskar N Rao, Andrew M Davidoff, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2012
Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's diseaseJennifer L Furman, Diana M Sama, John C Gant, et al.Depression and Anxiety|March 19, 2020
Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkersGustavo C Medeiros, A John Rush, Manish Jha, et al.Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.Pageof 29